Clinical Relevance of Circulating Tumour Cells in the Bone Marrow of Patients with SCCHN

Abstract

The detection of minimal residual disease underlines the understanding of SCCHN as a systemic disease. Further examination of such cells will lead to a better understanding of the tumour biology, as well as to improvement of diagnostic and therapeutic strategies.